IN THIS ISSUE
Legislation & Regulation
John Carroll
Large insurers worry what will become of the hard work and money expended on the conversion if some providers get their way
Medication Management
Thomas Reinke
Formulary managers need to make head-to-head comparisons of dabigatran and other anticoagulants used to treat atrial fibrillation
Evidence Review
A summary of ECRI Institute’s Emerging Technology Evidence Report
Tomorrow's Medicine
Thomas Morrow, MD
Elelyso, derived from plant-cell technology, avoids many of the problems encountered when mammalian cells are used to create drugs
News & Commentary
News & Commentary